Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Labella Álvarez

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Neurology|December 17, 2025
Optic nerve sheath enhancement in patients with a new diagnosis of idiopathic intracranial hypertensionFernando Labella Álvarez, Amit M Saindane, Valérie Biousse, et al.
Eye (London, England)|September 18, 2025
Infographic: landmark trials in Neuro-Ophthalmology-results of the phase II idiopathic intracranial hypertension drug trialMichael Lowe, Gabriele Berman, Fernando Labella Álvarez, et al.
Practical Neurology|January 13, 2026
How to diagnose papilloedemaMichael C Lowe, Gabriele Berman, Fernando Labella Álvarez, et al.
Journal of Neurology|April 15, 2024
Applying the 2022 optic neuritis criteria to noninflammatory optic neuropathies with optic nerve T2-hyperintensity: an observational studyFernando Labella Álvarez, Valérie Biousse, Rasha Mosleh, et al.
Eye (London, England)|February 14, 2024
Glaucoma as a cause of optic nerve abnormalities on magnetic resonance imagingRasha Mosleh, Fernando Labella Álvarez, Walid Bouthour, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 22, 2024
Optic Nerve MRI T2-Hyperintensity: A Nonspecific Marker of Optic Nerve DamageFernando Labella Álvarez, Rasha Mosleh, Walid Bouthour, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Neurology|December 17, 2025
Optic nerve sheath enhancement in patients with a new diagnosis of idiopathic intracranial hypertensionFernando Labella Álvarez, Amit M Saindane, Valérie Biousse, et al.
Eye (London, England)|September 18, 2025
Infographic: landmark trials in Neuro-Ophthalmology-results of the phase II idiopathic intracranial hypertension drug trialMichael Lowe, Gabriele Berman, Fernando Labella Álvarez, et al.
Practical Neurology|January 13, 2026
How to diagnose papilloedemaMichael C Lowe, Gabriele Berman, Fernando Labella Álvarez, et al.
Journal of Neurology|April 15, 2024
Applying the 2022 optic neuritis criteria to noninflammatory optic neuropathies with optic nerve T2-hyperintensity: an observational studyFernando Labella Álvarez, Valérie Biousse, Rasha Mosleh, et al.
Eye (London, England)|February 14, 2024
Glaucoma as a cause of optic nerve abnormalities on magnetic resonance imagingRasha Mosleh, Fernando Labella Álvarez, Walid Bouthour, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 22, 2024
Optic Nerve MRI T2-Hyperintensity: A Nonspecific Marker of Optic Nerve DamageFernando Labella Álvarez, Rasha Mosleh, Walid Bouthour, et al.
Pageof 1